GTVI
Joway Health Industries Group Inc. [GTVI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GTVI Stock Summary
In the News
GTVI Financial details
Company Rating
Neutral
Market Cap
30.75M
Income
-74.71K
Revenue
0
Book val./share
-0.01
Cash/share
-
Dividend
-
Dividend %
-
Employees
21
Optionable
No
Shortable
Yes
Earnings
-
P/E
-46.9
Forward P/E
-
PEG
7.47
P/S
-
P/B
-19.83
P/C
-
P/FCF
-22137.28
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-45.92%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
140.48%
-
-
-
-
SMA20
18.52%
SMA50
113.33%
SMA100
-8.57%
Inst Own
-
Inst Trans
-
ROA
-
ROE
50%
ROC
0.42%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
202.29M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
0.0257-0.62
52W High
-
52W Low
-
RSI
33.85
Rel Volume
0.31
Avg Volume
8.18K
Volume
2.5K
Perf Week
-56.56%
Perf Month
-23.23%
Perf Quarter
-47.59%
Perf Half Y
-55.16%
-
-
-
-
Beta
-
-
-
Volatility
0.07%, 0.07%
Prev Close
-53.09%
Price
0.152
Change
-53.09%
GTVI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.08 | 0.03 | 0 | 0 | 0 | |
| Net income per share | -0.08 | -0.06 | -0.12 | -0.01 | 0 | |
| Operating cash flow per share | -0.04 | -0.04 | -0.03 | 0 | 0 | |
| Free cash flow per share | -0.04 | -0.04 | -0.03 | 0 | 0 | |
| Cash per share | 0.01 | 0 | 0 | 0 | 0 | |
| Book value per share | 0.21 | 0.15 | -0.04 | -0.01 | -0.01 | |
| Tangible book value per share | 0.19 | 0.13 | -0.04 | -0.01 | 0 | |
| Share holders equity per share | 0.21 | 0.15 | -0.04 | -0.01 | -0.01 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 842.27K | 1M | 3.01M | 822.21K | 1.66M | |
| Enterprise value | 764.24K | 958.51K | 3.01M | 822.21K | 1.66M | |
| P/E ratio | -0.55 | -0.81 | -1.29 | -6.75 | -22.28 | |
| Price to sales ratio | 0.5 | 1.65 | 0 | 0 | 0 | |
| POCF ratio | -0.95 | -1.3 | -5.33 | -11.73 | 0 | |
| PFCF ratio | -0.94 | -1.16 | -5.33 | -11.73 | 0 | |
| P/B Ratio | 0.2 | 0.34 | -4.04 | -7.68 | -9.36 | |
| PTB ratio | 0.2 | 0.34 | -4.04 | -7.68 | -9.36 | |
| EV to sales | 0.46 | 1.57 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -0.71 | -1.18 | -1.29 | -6.75 | -22.28 | |
| EV to operating cash flow | -0.86 | -1.24 | -5.33 | -11.73 | 0 | |
| EV to free cash flow | -0.85 | -1.11 | -5.33 | -11.73 | 0 | |
| Earnings yield | -1.81 | -1.23 | -0.77 | -0.15 | -0.04 | |
| Free cash flow yield | -1.06 | -0.86 | -0.19 | -0.09 | 0 | |
| Debt to equity | 0.21 | 0.56 | -1.16 | -1 | 0 | |
| Debt to assets | 0.17 | 0.36 | 7.26 | 0 | 0 | |
| Net debt to EBITDA | 0.07 | 0.05 | 0 | 0 | 0 | |
| Current ratio | 1.03 | 0.47 | 0.14 | 0 | 0 | |
| Interest coverage | -4.58K | -7.02K | 0 | 0 | 0 | |
| Income quality | 0.58 | 0.62 | 2.53 | 0.58 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0.14 | 0 | |
| Payout ratio | 0 | 0 | 0 | -0.98 | 0 | |
| Sales general and administrative to revenue | 0.96 | 1.94 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.09 | 0.1 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.01 | 0.12 | 0 | 0 | 0 | |
| Capex to revenue | 0 | -0.15 | 0 | 0 | 0 | |
| Capex to depreciation | -0.02 | -0.21 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.6 | 0.45 | 0.31 | 0.03 | 0.03 | |
| ROIC | -0.31 | -0.27 | -1.87 | 0 | 0 | |
| Return on tangible assets | -0.33 | -0.3 | -19.52 | 0 | 0 | |
| Graham Net | -0.02 | -0.06 | -0.04 | -0.01 | 0 | |
| Working capital | 26.69K | -867.33K | -744.89K | -107.05K | -177.76K | |
| Tangible asset value | 3.77M | 2.51M | -744.89K | -107.05K | 0 | |
| Net current asset value | 26.69K | -867.33K | -744.89K | -107.05K | 0 | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 60.68K | 40.66K | 73.91K | 59.54K | 0 | |
| Average payables | 63.83K | 95.16K | 46.04K | 0 | 0 | |
| Average inventory | 575.12K | 516.14K | 250.13K | 0 | 0 | |
| Days sales outstanding | 11.5 | 17.22 | 0 | 0 | 0 | |
| Days payables outstanding | 48.91 | 113.65 | 0 | 0 | 0 | |
| Days of inventory on hand | 264.86 | 617.5 | 0 | 0 | 0 | |
| Receivables turnover | 31.75 | 21.2 | 0 | 0 | 0 | |
| Payables turnover | 7.46 | 3.21 | 0 | 0 | 0 | |
| Inventory turnover | 1.38 | 0.59 | 0 | 0 | 0 | |
| ROE | -0.36 | -0.42 | 3.12 | 1.14 | 0.42 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Tangible book value per share | -0.01 | -0.01 | -0.01 | -0.01 | 0 | |
| Share holders equity per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 822.21K | 1.2M | 4.41M | 5.42M | 1.66M | |
| Enterprise value | 822.21K | 1.2M | 4.41M | 5.42M | 1.66M | |
| P/E ratio | -14.33 | -29.11 | -36.41 | -135.21 | -17.29 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -591.95 | 0 | 0 | 0 | 0 | |
| PFCF ratio | -591.95 | 0 | 0 | 0 | 0 | |
| P/B Ratio | -7.68 | -10.61 | -30.71 | -35.24 | -9.36 | |
| PTB ratio | -7.68 | -10.61 | -30.71 | -35.24 | -9.36 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -57.31 | -116.44 | -145.63 | -540.85 | -69.17 | |
| EV to operating cash flow | -591.95 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | -591.95 | 0 | 0 | 0 | 0 | |
| Earnings yield | -0.02 | -0.01 | -0.01 | 0 | -0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | -1 | -1 | -1 | -1 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.1 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -0.01 | -0.01 | -0.01 | -0.01 | 0 | |
| Working capital | -107.05K | -113.39K | -143.68K | -153.7K | -177.76K | |
| Tangible asset value | -107.05K | -113.39K | -143.68K | -153.7K | 0 | |
| Net current asset value | -107.05K | -113.39K | -143.68K | -153.7K | 0 | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.13 | 0.09 | 0.21 | 0.07 | 0.14 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
GTVI Frequently Asked Questions
What is Joway Health Industries Group Inc. stock symbol ?
Joway Health Industries Group Inc. is a US stock , located in Las vegas of Nv and trading under the symbol GTVI
What is Joway Health Industries Group Inc. stock quote today ?
Joway Health Industries Group Inc. stock price is $0.152 today.
Is Joway Health Industries Group Inc. stock public?
Yes, Joway Health Industries Group Inc. is a publicly traded company.
Company Profile
- Volume Average 8.18K
- Market Capitalization 30.75M
- Employee 21
- CEO Mr. Steven Zachariah Rudofsky
- Headquarters Las Vegas,NV,US
- IPO Date 2010-03-10
Joway Health Industries Group Inc. does not have significant operations. Previously, it was engaged in the manufacture and sale of tourmaline-related healthcare products. The company is based in Las Vegas, Nevada. Joway Health Industries Group Inc. is a subsidiary of JHP Holdings, Inc.
